Activation of microglia by histamine and substance P

Cellular Physiology and Biochemistry

Volumn 34, Issue 3, 2014, Pages 768-780

  Zhu, Jin ^a   Qu, Chen ^b   Lu, Xiang ^b   Zhang, Shu ^a  

^a THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^b THE SECOND AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

Author keywords

CNS immune inflammation; Histamine; Microglial activation; Substance P

Indexed keywords

CETIRIZINE; HISTAMINE; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; N [ALPHA (METHOXYCARBONYL)BENZYL] 2 PHENYL 4 QUINOLINECARBOXAMIDE; REACTIVE OXYGEN METABOLITE; SUBSTANCE P; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR;

ANIMAL CELL; ARTICLE; CELL ACTIVATION; CELL MEMBRANE DEPOLARIZATION; CELL SURVIVAL; CELL VIABILITY ASSAY; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; FLUOROMETRY; IMMUNOFLUORESCENCE; MICROGLIA; MICROGLIAL CELL CULTURE; MITOCHONDRIAL MEMBRANE POTENTIAL; MTT ASSAY; NONHUMAN; PRIORITY JOURNAL; RAT; UPREGULATION; ANIMAL; DRUG EFFECTS; FLUORESCENT ANTIBODY TECHNIQUE; METABOLISM;

ANIMALS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLUORESCENT ANTIBODY TECHNIQUE; HISTAMINE; INTERLEUKIN-6; MICROGLIA; RATS; REACTIVE OXYGEN SPECIES; SUBSTANCE P; TUMOR NECROSIS FACTORS;

EID: 84906583003     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000363041     Document Type: Article

References (54)

1. Csuka E, Hans VH, Ammann E, Trentz O, Kossmann T, Morganti-Kossmann MC: Cell activation and inflammatory response following traumatic axonal injury in the rat. Neuroreport 2000;11:2587-2590.
2. Popovich PG: Immunological regulation of neuronal degeneration and regeneration in the injured spinal cord. Prog Brain Res 2000;128:43-58.
3. Gao HM, Liu B, Zhang W, Hong JS: Novel anti-inflammatory therapy for Parkinson's disease. Trends Pharmacol Sci 2003;24:395-401.
4. Heppner FL, Greter M, Marino D, Falsig J, Raivich G, Hovelmeyer N, Waisman A, Rulicke T, Prinz M, Priller J, Becher B, Aguzzi A: Experimental autoimmune encephalomyelitis repressed by microglial paralysis. Nat Med 2005;11:146-152.
5. Block ML, Hong JS: Microglial and inflammation-mediated neurodegeneration: multiple triggers with a common mechanism. Prog Neurobiol 2005;76:77-98.
6. Herrera AJ, Tomas-Camardiel M, Venero JL, Cano J, Machado A: Inflammatory process as a determinant factor for the degeneration of substantia nigra dopaminergic neurons. J Neural Transm 2005;112:111-119.
7. Jutel M, Watanabe T, Klunker S, Akdis M, Thomet OA, Malolepszy J, Zak-Nejmark T, Koga R, Kobayashi T, Blaser K, Akdis CA: Histamine regulates T-cell and antibody responses by differential expression of H1 and H2 receptors. Nature 2001;413:420-425.
8. Akdis CA and Simons FE: Histamine receptors are hot in immunopharmacology. Eur J Pharmacol 2006;533:69-76.
9. Repka-Ramirez MS and Baraniuk JN: Histamine in health and disease. Clin Allergy Immunol 2002;17:1-25.
10. Tiligada E, Zampeli E, Sander K, Stark H: Histamine H3 and H4 receptors as novel drug targets. Expert Opinion on Investigating Drugs 2009;18:1519-1531.
11. Huang JF and Thurmond RL: The new biology of histamine receptors. Current Allergy and Asthma Reports 2008;8:21-27.
12. Maggi CA: Principles of tachykininergic co-transmission in the peripheral and enteric nervous system. Regul Pept 2000;93:53-64.
13. Holzer P, Holzer-Petsche U: Tachykinins in the gut. Part II. Roles in neural excitation, secretion, and inflammation. Pharmacol Ther 1997;73:219-263.
14. O'Connor TM, O'Connell J, O'Brien DI, Goode T, Bredin CP, Shanahan F: The role of substance P in inflammatory disease. J Cell Physiol 2004;201:167-180.
15. Donkin JJ, Turner RJ, Hassan I, Vink R: Substance P in traumatic brain injury. Prog Brain Res 2007;161:97-109.
16. Ebner K, Singewald N: The role of substance P in stress and anxiety responses. Amino Acids 2006;31:251-272.
17. Kincy-Cain T, Bost KL: Increased susceptibility of mice to Salmonellainfection following in vivo treatment with the substance P antagonist, spantide II. J Immunol 1996;157:255-264.
18. Bozic CR, Lu B, Hopken UE,Gerard C, Gerard NP: Neurogenic amplification of immune complex inflammation. Science 1996;273:1722-1725.
19. Marriott I, Bost KL: IL-4 and IFN-γ up-regulate substance P receptor expression in murine peritoneal macrophages. J Immunol 2000;165:182-191.
20. Marriott I, Bost KL: Expression of authentic substance P receptors in murine and human dendritic cells. J Neuroimmunol 2001;114:131-141.
21. Holzer P, Schluet W, Maggi CA: Substance P stimulates and inhibits intestinal peristalsis via distinct receptors. J Pharmacol Exp Ther 1995;274:322-328.
22. Rasley A, Bost KL, Olson JK, Miller SD, Marriott I: Expression of functional NK-1 receptors in murine microglia. Glia 2002;373:258-267.
23. Zhang S, Zeng X, Yang H, Hu G, He S: Mast cell tryptase induces microglia activation via protease-activated receptor 2 signaling. Cell Physiol Biochem 2012;29:931-940.
24. Gao HM, Hong JS, Zhang W, Liu B: Distinct role for microglial in rotenone-induced degeneration of dopaminergic neurons. J Neurosci 2002;22:782-790.
25. Friberg H, Wieloch T, Castilho RF: Mitochondrial oxidative stress after global brain ischemia in rats. Neuroscience Lett 2002;334:111-114.
26. Sullivan PG, Thompson MB, Scheff SW: Cyclosporin A attenuates acute mitochondrial dysfunction following traumatic brain injury. Exp Neurol 1999;160:226-234.
27. Minghetti L: Role of inflammation in neurodegenerative diseases. Curr Opin Neurol 2005;18:315-321.
28. Streit WJ, Conde JR, Fendrick SE, Flanary BE, Mariani CL: Role of microglia in the central nervous system's immune response. Neurol Res 2005;27:685-691
29. Tweedie D, Sambamurti K, Greig NH: TNF-alpha inhibition as a treatment strategy for neurodegenerative disorders: new drug candidates and targets. Curr Alzheimer Res 2007;4:378-385.
30. Gruol DL, Nelson TE: Physiological and pathological roles of interleukin-6 in the central nervous system. Mol Neurobiol 1997;15:307-339.
31. Linker RA, Lühder F, Kallen KJ, Lee DH, Engelhardt B, Rose-John S, Gold R: IL-6 transsignalling modulates the early effector phase of EAE and targets the blood-brain barrier. J Neuroimmunol 2008;205:64-72.
32. Quintana A, Müller M, Frausto RF, Ramos R, Getts DR, Sanz E, Hofer MJ, Krauthausen M, King NJ, Hidalgo J, Campbell IL: Site-specific production of IL-6 in the central nervous system retargets and enhances the inflammatory response in experimental autoimmune encephalomyelitis. J Immunol 2009;183:2079-2088.
33. Wei H, Zou H, Sheikh A, Malik M, Dobkin C, Brown T, Li X: IL-6 is increased in the cerebellum of the autistic brain and alters neural cell adhesion, migration and synapse formation. J Neuroinflammation 2011;8:52.
34. Gadient RA, Otten UH: Interleukin-6 (IL-6)-a molecule with both beneficial and destructive potentials. Prog Neurobiol 1997;52:379-390.
35. Ikarashi Y and Yuzurihara M: Experimental anxiety induced by histaminergics in mast cell-deficient and congenitally normal mice. Pharmacol Biochem Behav 2002;72:437-441.
36. Crivellato E, Beltrami CA, Mallardi F, Ribatti D: The mast cell: an active participant or an innocent bystander? Histol Histopathol 2004;19:259-270.
37. Ferreira R, Santos T, Gonçalves J, Baltazar G, Ferreira L, Agasse F, Bernardino L: Histamine modulates microglia function. J Neuroinflammation 2012;9:90.
38. Wei J, Wu F, Sun X, Zeng X, Liang JY, Zheng HQ, Yu XB, Zhang KX, Wu ZD: Differences in microglia activation between rats-derived cell and mice-derived cell after stimulating by soluble antigen of IV larva from Angiostrongylus cantonensis in vitro. Parasitol Res 2013;112:207-214.
39. Meda L, Baron P, Prat E, Scarpini E, Scarlato G, Cassatella MA, Rossi F: Proinflammatory profile of cytokine production by human monocytes and murine microglia stimulated with beta-amyloid[25-35]. J Neuroimmunol 1999;93:45-52.
40. Block ML, Zecca L, Hong JS: Microglia-mediated neurotoxicity: uncovering the molecular mechanisms. Nat Rev Neurosci 2007;8:57-69.
41. Wilkinson BL, Landreth GE: The microglial NADPH oxidase complex as a source of oxidative stress in Alzheimer's disease. J Neuroinflammation 2006;3:30-41.
42. Akundi RS, Candelario-Jalil E, Hess S, Hull M, Lieb K, Gebicke-Haerter PJ, Fiebich BL: Signal transduction pathways regulating cyclooxygenase-2 in lipopolysaccharide-activated primary rat microglia. Glia 2005;51:199-208.
43. Ciallella JR, Saporito M, Lund S, Leist M, Hasseldam H, McGann N, Smith CS, Bozyczko-Coyne D, Flood DG: CEP-11004, an inhibitor of the SAPK/JNK pathway, reduces TNF-alpha release from lipopolysaccharidetreated cells and mice. Eur J Pharmacol 2005;515:179-187.
44. Lund S, Porzgen P, Mortensen AL, Hasseldam H, Bozyczko-Coyne D, Morath S, Hartung T, Bianchi M, Ghezzi P, Bsibsi M, Dijkstra S, Leist M: Inhibition of microglial inflammation by the MLK inhibitor CEP-1347. J Neurochem 2005;92:1439-1451.
45. Waetzig V, Czeloth K, Hidding U, Mielke K, Kanzow M, Brecht S, Goetz M, Lucius R, Herdegen T, Hanisch UK: c-Jun N-terminal kinases (JNKs) mediate proinflammatory actions of microglia. Glia 2005;50:235-246.
46. Marriott I, Bost KL: Substance P receptor mediated macrophage responses. Adv Exp Med Biol 2001;493:247-254.
47. Lotz M, Vaughan JH, Carson DA: Effect of neuropeptides on production of inflammatory cytokines by human monocytes. Scienc 1988;241:1218-1221.
48. Laurenzi MA, Persson MA, Dalsgaard CJ, Haegerstrand A: The neuropeptide substance P stimulates production of interleukin 1 in human blood monocytes: activated cells are preferentially influenced by the neuropeptide. Scand J Immunol 1990;31:529-533.
49. Hartung HP, Wolters K, Toyka KV: Substance P: binding properties and studies on cellular responses in guinea pig macrophages. J Immunol 1986; 36:3856-3863.
50. Luber-Narod J, Kage R, Leeman SE: Substance P enhances the secretion of tumor necrosis factor-alpha from neuroglial cells stimulated with lipopolysaccharide. J Immunol 1994;152:819-824.
51. Lai JP, Zhan GX, Campbell DE, Douglas SD, Ho WZ: Detection of substance P and its receptor in human fetal microglia. Neuroscience 2000;101:1137-1144.
52. Rasley A, Marriott I, Halberstadt CR, Bost KL, Anguita J: Substance P augments Borrelia burgdorferi-induced prostaglandin E2 production by murine microglia. J Immunol 2004;172:5707-5713.
53. Medina MA, Quesada AR, de Castro I, Sánchez-Jiménez F: Histamine, polyamines and cancer. Biochemical Pharmacology 1999;57:1341-1344.
54. Saligrama N, Noubade R, Case LK, del Rio R, Teuscher C: Combinatorial roles for histamine H1-H2 and H3-H4 receptors in autoimmune inflammatory disease of the central nervous system. Eur J Immunol 2012;42:1536-1546.